Abstract Details
Susanne Muehlschlegel, MD, MPH, FAAN
(Johns Hopkins School of Medicine)
PRESENTER |
Dr. Muehlschlegel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acasti Pharma Inc.. Dr. Muehlschlegel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acasti Pharma Inc.. The institution of Dr. Muehlschlegel has received research support from NIH. The institution of Dr. Muehlschlegel has received research support from NIH. The institution of an immediate family member of Dr. Muehlschlegel has received research support from NIH. Dr. Muehlschlegel has a non-compensated relationship as a Member of Board of Directors with Neurocritical Care Society that is relevant to AAN interests or activities. |
Sarah Perman | No disclosure on file |
Jonathan Elmer | No disclosure on file |
No disclosure on file | |
No disclosure on file | |
No disclosure on file | |
No disclosure on file | |
No disclosure on file | |
Renee Kasperek-Wynn | Renee Kasperek-Wynn has nothing to disclose. |
No disclosure on file | |
No disclosure on file | |
No disclosure on file | |
Robert Silbergleit | The institution of Robert Silbergleit has received research support from NIH. |